1. Home
  2. HOWL vs NTWK Comparison

HOWL vs NTWK Comparison

Compare HOWL & NTWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOWL
  • NTWK
  • Stock Information
  • Founded
  • HOWL 2017
  • NTWK 1997
  • Country
  • HOWL United States
  • NTWK United States
  • Employees
  • HOWL N/A
  • NTWK N/A
  • Industry
  • HOWL Biotechnology: Pharmaceutical Preparations
  • NTWK Computer Software: Prepackaged Software
  • Sector
  • HOWL Health Care
  • NTWK Technology
  • Exchange
  • HOWL Nasdaq
  • NTWK Nasdaq
  • Market Cap
  • HOWL 64.5M
  • NTWK 56.1M
  • IPO Year
  • HOWL 2021
  • NTWK 1998
  • Fundamental
  • Price
  • HOWL $1.56
  • NTWK $4.34
  • Analyst Decision
  • HOWL Strong Buy
  • NTWK
  • Analyst Count
  • HOWL 5
  • NTWK 0
  • Target Price
  • HOWL $7.20
  • NTWK N/A
  • AVG Volume (30 Days)
  • HOWL 1.3M
  • NTWK 87.3K
  • Earning Date
  • HOWL 11-14-2025
  • NTWK 11-11-2025
  • Dividend Yield
  • HOWL N/A
  • NTWK N/A
  • EPS Growth
  • HOWL N/A
  • NTWK 316.67
  • EPS
  • HOWL N/A
  • NTWK 0.25
  • Revenue
  • HOWL N/A
  • NTWK $66,088,229.00
  • Revenue This Year
  • HOWL N/A
  • NTWK N/A
  • Revenue Next Year
  • HOWL N/A
  • NTWK N/A
  • P/E Ratio
  • HOWL N/A
  • NTWK $18.00
  • Revenue Growth
  • HOWL N/A
  • NTWK 7.65
  • 52 Week Low
  • HOWL $0.60
  • NTWK $2.14
  • 52 Week High
  • HOWL $2.96
  • NTWK $5.75
  • Technical
  • Relative Strength Index (RSI)
  • HOWL 45.71
  • NTWK 44.93
  • Support Level
  • HOWL $1.55
  • NTWK $4.30
  • Resistance Level
  • HOWL $1.83
  • NTWK $4.69
  • Average True Range (ATR)
  • HOWL 0.13
  • NTWK 0.20
  • MACD
  • HOWL -0.03
  • NTWK -0.03
  • Stochastic Oscillator
  • HOWL 14.71
  • NTWK 13.85

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

About NTWK NetSol Technologies Inc. Common Stock

NETSOL Technologies Inc is an information technology and enterprise software solutions provider to original equipment manufacturers (OEMs), dealerships, and financial institutions to sell, finance, and lease assets. The firm's products include Transcend Retail, Transcend Finance, Transcend Marketplace, Transcend Consultancy, and Transcend AI Labs, catering to its customers in the different stages of how assets are sold, financed, and leased. Its primary sources of revenue are licensing, subscriptions, modification, enhancement, and support of its suite of financial applications offered to businesses in the finance and leasing space, as well as automotive digital retail. The company has three reportable segments: Asia-Pacific, its key revenue-generating market, North America, and Europe.

Share on Social Networks: